中药联合穴位埋线治疗急性脑梗死的临床研究

目的：探讨中药汤剂联合穴位埋线对急性脑梗死患者的临床疗效。方法：将75例急性脑梗死患者随机分成治疗组和对照组,其中对照组37例,治疗组38例,对照组予基本治疗,治疗组在基本治疗的基础上加用中药汤剂并联合穴位埋线治疗。取穴：廉泉、肩髃、曲池、合谷、环跳、足三里、丰隆、三阴交并检测治疗前后超敏-C反应蛋白、D-二聚体、纤维蛋白原,血液流变学指标;检测血脂;评定神经功能缺损评分及中医症候评分。疗程为2周。结果：两组治疗后hs-CRP,D-Dimer,Fig均较治疗前有下降,然而治疗组治疗后hs-CRP,D-Dimer,Fig较对照组治疗后下降明显,差异有统计学意义（P〈0.05）;治疗组治疗后血液流变学指标改善较对照组更明显（P〈0.05）。两组血脂改变组间无差异（P〉0.05）;治疗后NIHSS及中医症候评分治疗组较对照组降低更为明显（P〈0.05）。结论：中药联合穴位埋线治疗可显著改善急性脑梗死患者的神经功能缺损评分及中医症候评分,降低急性脑梗死患者血清中hs-CRP、D-Dimer、Fig含量,改善血液流变学指标,有一定的临床应用价值。

Clinical Research of Traditional Chinese Medicine Combined with Catgut Implantation at Acupoiont on Acute Cerebral Infarction

Objective：To evaluate the clinical effective of Chinese medicine decoction combined with catgut implantation at acupoint. Methods ：75 patients were randomly divided into the treatment and the control groups. The basic treatment was given to the control group and Chinese medicine decoction combined with catgut implantation at acupoint was given to the treatment besides the basic treatment. Acupiont selection ： Lianquan （ CV23 ） ,Jianyu （ LI15 ）, Quchi （ LI11 ）, Hegu （ LI4 ）, Huantiao （ GB30 ）, Zusanli （ ST36 ） , Fenglong （S40 ）, a period of treatment was two weeks. On the first, the fifteenth day of treatment,75 patients were asked for TCM symptom score and NIHSS, the concentrations of serum hs - CRP, D- Dimer, Fig, lipid levels and the hemorheology indexes. Results：The treatment group＇s TCM score and NIHSS score were better declined than that of the control group on the fifteenth day （ P 〈 0.05 ）. And the concentrations of serum hs - CRP, D - Dimer, Fig and the hemorheology indexes were better declined than those of the control group（ P 〈 0.05 ）. But there was no statistically significant difference of lipid changes between the two groups （P 〉 0.05 ）. Conclusions：The method of Chinese medicine decoction combined with catgut implantation at acupoint can significantly decrease the score of NIHSS and TCM symptom, decrease serum hs - CRP, D - Dimer, Fig content and improve hemorheology indexes.